ClinicalMetric / Countries / Hungary / t cell lymphoma
← 🇭🇺 Hungary Trials
🇭🇺 Hungary Country × Condition

t cell lymphoma Clinical Trials in Hungary

Active clinical trials for t cell lymphoma with research sites in Hungary. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇭🇺 Hungary

Active Trials in Hungary (1)

NCT04752826 Phase 1, Phase 2
Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Enrollment
176 pts
Country
🇭🇺 Hungary
BioInvent International AB
View Trial →

Frequently Asked Questions

How many t cell lymphoma clinical trials are active in Hungary?
There are currently 1 active clinical trials for t cell lymphoma with sites in Hungary, of which 1 are actively recruiting patients.
How can I join a t cell lymphoma clinical trial in Hungary?
To join a t cell lymphoma clinical trial in Hungary, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Hungary directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are t cell lymphoma trials in Hungary?
Active t cell lymphoma trials in Hungary span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Hungary Trials → Global t cell lymphoma Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology